ǥ :
|
ȣ - 470446 129 |
Endothelial Progenitor Cells From Patients With End-Stage Renal Diesase Exhibit Impaired Proliferation, Migration, And Incorporation Into Vascular Structures |
Sungkyunkwan University School of Medicine, Samsung Medical Center, Dept of Cardiology¹, Dept of Nephrology² |
Jin-Ho Choi¹, Kyung Ree Kim,MS¹, Il Seok Cheon,MD¹, Bum Kim,MD², Hyung-Suk Jang,MS¹, Jeong-Min Kim,BS¹, Jae-Young Lee,MS¹, Yong Sam Lee,MS¹, Woo Sung Huh,MD², Ha Young Oh,MD², Eun-Seok Jeon,MD¹, Won-Hee Seo,PhD¹, Jong Hoe Byun,PhD¹ and Duk-Kyung Kim, MD¹ |
Background : Patients with end-stage renal disease (ESRD) show markedly
increased mortality due to atherosclerosis. Because importance of endothelial
progenitor cells (EPCs) contribution in vascular function and cumulative
cardiovascular risk have been demonstrated, EPC dysfunction may be important
in pathophysiology of ESRD.
Material and Results : EPC were isolated from ESRD patients on maintenance
hemodialysis patients (n=44) and age-matched control subjects (n=30). EPC of
ESRD patients showed colony formation decreased by 75.3% and proliferation
of characteristic spindle-shaped EPC decreased by 44.6% when compared to
control subjects (p<0.001). These findings were corroborated by 48.8%
decrease of EPC incorporation into HUVEC (p<0.001), and 69.5% decrease of
migration in response to VEGF (p=0.040). Moreover, Dialysis clearance
measured by Kt/V was strongly correlated with EPC incorporation (r=0.427,
p=0.004).
Conclusions : This is the first clinical demonstration showing that EPC
biology, which is critical for new vessel growth, is altered in ESRD. Our
data suggest that dysfunction of circulating EPC may have a role in
progression of cardiovascular disease in ESRD patients.
|
|
|
|